122 related articles for article (PubMed ID: 37381675)
1. Physical training promotes remodeling of the skeletal muscle extracellular matrix: An ultrastructural study in a murine model of Down syndrome.
Cisterna B; Boschi F; Lacavalla MA; Vattemi GNA; Zancanaro C; Malatesta M
Microsc Res Tech; 2023 Nov; 86(11):1517-1528. PubMed ID: 37381675
[TBL] [Abstract][Full Text] [Related]
2. A computational approach to quantitatively define sarcomere dimensions and arrangement in skeletal muscle.
Cisterna B; Malatesta M; Zancanaro C; Boschi F
Comput Methods Programs Biomed; 2021 Nov; 211():106437. PubMed ID: 34624632
[TBL] [Abstract][Full Text] [Related]
3. Physical Training Chronically Stimulates the Motor Neuron Cell Nucleus in the Ts65Dn Mouse, a Model of Down Syndrome.
Inguscio CR; Lacavalla MA; Cisterna B; Zancanaro C; Malatesta M
Cells; 2023 May; 12(11):. PubMed ID: 37296609
[TBL] [Abstract][Full Text] [Related]
4. Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome.
Cisterna B; Sobolev AP; Costanzo M; Malatesta M; Zancanaro C
Microsc Microanal; 2020 Oct; 26(5):1014-1023. PubMed ID: 32867866
[TBL] [Abstract][Full Text] [Related]
5. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
[TBL] [Abstract][Full Text] [Related]
6. Quantitative magnetic resonance characterization of the effect of physical training on skeletal muscle of the Ts65Dn mice, a model of Down syndrome.
Cisterna B; Bontempi P; Sobolev AP; Costanzo M; Malatesta M; Zancanaro C
Quant Imaging Med Surg; 2022 Mar; 12(3):2066-2074. PubMed ID: 35284271
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural features of skeletal muscle in adult and aging Ts65Dn mice, a murine model of Down syndrome.
Cisterna B; Costanzo M; Scherini E; Zancanaro C; Malatesta M
Muscles Ligaments Tendons J; 2013 Oct; 3(4):287-94. PubMed ID: 24596692
[TBL] [Abstract][Full Text] [Related]
8. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.
Blazek JD; Gaddy A; Meyer R; Roper RJ; Li J
Bone; 2011 Feb; 48(2):275-80. PubMed ID: 20870049
[TBL] [Abstract][Full Text] [Related]
9. Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.
Billingsley CN; Allen JR; Baumann DD; Deitz SL; Blazek JD; Newbauer A; Darrah A; Long BC; Young B; Clement M; Doerge RW; Roper RJ
Am J Med Genet A; 2013 Aug; 161A(8):1866-74. PubMed ID: 23843306
[TBL] [Abstract][Full Text] [Related]
10. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
von Kaisenberg CS; Krenn V; Ludwig M; Nicolaides KH; Brand-Saberi B
Anat Embryol (Berl); 1998 Feb; 197(2):105-24. PubMed ID: 9497154
[TBL] [Abstract][Full Text] [Related]
11. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.
Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ
Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991
[TBL] [Abstract][Full Text] [Related]
12. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
[TBL] [Abstract][Full Text] [Related]
13. Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a.
Blazek JD; Abeysekera I; Li J; Roper RJ
Hum Mol Genet; 2015 Oct; 24(20):5687-96. PubMed ID: 26206885
[TBL] [Abstract][Full Text] [Related]
14. Developmental instability of the cerebellum and its relevance to Down syndrome.
Shapiro BL
J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737
[TBL] [Abstract][Full Text] [Related]
15. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
[TBL] [Abstract][Full Text] [Related]
16. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
Blazek JD; Billingsley CN; Newbauer A; Roper RJ
Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361
[TBL] [Abstract][Full Text] [Related]
17. Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier.
Li H; Edie S; Klinedinst D; Jeong JS; Blackshaw S; Maslen CL; Reeves RH
Genetics; 2016 Jun; 203(2):763-70. PubMed ID: 27029737
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular development and survival during gestation in the Ts65Dn mouse model for Down syndrome.
Lorandeau CG; Hakkinen LA; Moore CS
Anat Rec (Hoboken); 2011 Jan; 294(1):93-101. PubMed ID: 21157920
[TBL] [Abstract][Full Text] [Related]
19. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
20. Perinatal loss of Ts65Dn Down syndrome mice.
Roper RJ; St John HK; Philip J; Lawler A; Reeves RH
Genetics; 2006 Jan; 172(1):437-43. PubMed ID: 16172497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
